A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe and evaluate the efficacy and safety of Camrelizumab
combined with or without radiotherapy for the treatment of recurrent or metastatic esophageal
cancer that has progressed after chemotherapy